Relationship between antibody-dependent cellular cytotoxicity, plasma HIV type 1 RNA, and CD4+ lymphocyte count

AIDS Research and Human Retroviruses

Volumn 17, Issue 6, 2001, Pages 553-561

  Forthal, D N ^a   Landucci, G ^a   Keenan, B ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY ANTIBODY; ANTIRETROVIRUS AGENT; CHROMIUM 51; UNCLASSIFIED DRUG; VIRUS RNA;

ADULT; AGED; ANALYTIC METHOD; ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ARTICLE; CELL FUNCTION; CLINICAL ARTICLE; CONTROLLED STUDY; EFFECTOR CELL; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; INFECTION CONTROL; LYMPHOCYTE COUNT; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL; VIREMIA; VIRUS ISOLATION; VIRUS LOAD;

ANTI-HIV AGENTS; ANTIBODY-DEPENDENT CELL CYTOTOXICITY; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; HIV INFECTIONS; HIV-1; HUMANS; RNA, VIRAL; VIRAL LOAD;

EID: 0034915448     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/08892220151126661     Document Type: Article

References (35)

1. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma
2. Early protective effect of CCR-5 delta 32 heterozygosity on HIV-1 disease progression: Relationship with viral load. The SEROCO Study Group
3. Evolution of human immunodeficiency virus type 1 in perinatally infected infants with rapid and slow progression to disease
4. Strong cytotoxic T cell and weak neutralizing antibody responses in a subset of persons with stable nonprogressing HIV type 1 infection
5. Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA
6. Immunologic and virologic status after 14 to 18 years of infection with an attenuated strain of HIV-1. A report from the Sydney Blood Bank Cohort
7. Antibody-dependent cellular cytotoxicity in HIV infections
8. HIV-1 gp120-specific antibody-dependent cell-mediated cytotoxicity correlates with rate of disease progression
9. Antibody-dependent cellular cytotoxicity independently predicts survival in severely immunocompromised human immunodeficiency virus-infected patients
10. Passive infusion of immune serum into simian immunodeficiency virus-infected rhesus macaques undergoing a rapid disease course has minimal effect on plasma viremia
11. Cytokine expression, natural killer cell activation, and phenotypic changes in lymphoid cells from rhesus macaques during acute infection with pathogenic simian immunodeficiency virus
12. Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes
13. CD56 identifies monocytes and not natural killer cells in rhesus macaques
14. Spontaneous human lymphocyte-mediated cytotoxicity against tumor target cells. IX. The quantitation of natural killer cell activity
15. In vitro reduction of virus infectivity by antibody-dependent cell-mediated immunity
16. Mechanism of defective NK cell activity in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. II. Normal antibody-dependent cellular cytotoxicity (ADCC) mediated by effector cells defective in natural killer (NK) cytotoxicity
17. MHC class I alloantigen specificity of Ly-49+ IL-2-activated natural killer cells
18. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA
19. Peripheral blood monocytes derived from HIV+ individuals mediate antibody-dependent cellular cytotoxicity (ADCC)
20. Role of antibody-dependent cellular cytotoxicity and lymphokine-activated killer cells in AIDS and related diseases
21. Alterations in antibody-dependent cellular cytotoxicity during the course of HIV-1 infection. Humoral and cellular defects
22. Antibody-dependent cellular cytotoxicity mediated by CD16+ lymphocytes from HIV-seropositive homosexual men
23. A novel antibody-dependent cellular cytotoxicity epitope in gp120 is identified by two monoclonal antibodies isolated from a long-term survivor of human immunodeficiency virus type 1 infection
24. Interleukin-2 production used to detect antigenic peptide recognition by T-helper lymphocytes from asymptomatic HIV-seropositive individuals
25. Ability of HIV to promote a TH1 to TH0 shift and to replicate preferentially in TH2 and TH0 cells
26. Lymphokine-activated killer (LAK) cell anti-HIV-1 ADCC reactivity: A potential strategy for reduction of virus-infected cellular reservoirs
27. Evidence for a defect of antibody-dependent cellular cytotoxic (ADCC) effector function and anti-HIV gp120/41-specific ADCC-mediating antibody titres in HIV-infected individuals
28. Normal human serum restores the expression of Fc gamma receptors in immune complex-blocked human mononuclear cells
29. Detection of infectious immune complexes in human immunodeficiency virus type 1 (HIV-1) infections: Correlation with plasma viremia and CD4 cell counts
30. HIV-1-specific cytolytic T-lymphocyte activity correlates with lower viral load, higher CD4 count, and CD8+CD38-DR- phenotype: Comparison of statistical methods for measurement
31. Functional activities of 20 human immunodeficiency virus type 1 (HIV-1)-specific human monoclonal antibodies
32. Strong correlation between the complement-mediated antibody-dependent enhancement of HIV-1 infection and plasma viral load
33. The effect of highly active antiretroviral therapy on binding and neutralizing antibody responses to human immunodeficiency virus type 1 infection
34. Identification of sites within gp41 that serve as targets for antibody-dependent cellular cytotoxicity by using human monoclonal antibodies
35. Natural killer cells from human immunodeficiency virus (HIV)-infected individuals are an important source of CC-chemokines and suppress HIV-1 entry and replication in vitro